Increases in COVID, RSV, and influenza are the result of governments refusal to enact public health measures and address ...

UKHSA study shows RSV vaccine highly effective in preventing hospitalisation: United Kingdom Saturday, August 2, 2025, 10:00 Hrs [IST] A new UK Health Security Agency study - Effe ...

A NEW vaccine to protect against a serious respiratory infection is now being offered on the high street. 60 community pharmacies across Cheshire, Merseyside, Lancashire and South Cumbria are now ...

Multiple healthcare organizations that have historically helped the CDC's Advisory Committee on Immunization Practices (ACIP) ...

Just one day after CEO Stéphane Bancel’s sudden announcement of a 10% workforce reduction, Moderna has released Q2 2025 that ...

Despite the overall decline in commercial product revenue, Moderna was also pleasantly surprised by Q2 Spikevax sales, which ...

It’s not often that a CEO outright dismisses M&A prospects, but Moderna CEO Stéphane Bancel says the mRNA biotech has enough ...

Moderna cut 2025 revenue by $300m after delaying UK Covid vaccine shipments to 2026, as Q2 results beat forecasts with ...

Pregnant individuals commonly reported hesitancy toward RSVpreF and nirsevimab, indicating the need for efforts to promote the safety and uptake of RSV immunization.

Several studies have now demonstrated that trained immunity occurs in the airways to several pathogens and products, while its utility is yet to be determined.